Latest Commercialization News

Rumble Resources’ latest Scoping Study reveals a promising underground gold mining project at Western Queen South with low capital costs and strong financial returns, setting the stage for rapid development and potential resource expansion.

ReNerve Ltd reports a strong 53% year-on-year revenue increase, expanding its US distribution network and advancing clinical studies for its nerve repair products. The company is poised for significant global market growth with new partnerships and upcoming product launches.

Axel REE Limited reveals a substantial inferred resource at its Caladão Project, advancing plans for in situ recovery trial mining in 2026 to produce rare earth and gallium products. The company’s low-cost, environmentally conscious approach positions it well within Brazil’s Lithium Valley mining hub.

Pathkey.AI has secured A$2.5 million through a placement and launched a nearly A$1 million rights issue to fund expansion of its AI-driven TrialKey platform and pursue strategic acquisitions, alongside key board changes.

Minbos Resources is advancing its Cabinda Phosphate and Capanda Green Ammonia projects with secured financing and construction underway, targeting first shipments in the first half of 2026. Strategic partnerships and government support underpin its ambitious plans to boost Angola’s agricultural and export sectors.

Redivium Limited has advanced its battery recycling ambitions with a binding offtake agreement alongside strategic funding plans, despite ongoing ASX suspension. The company’s new partnership with WMC Energy BV marks a pivotal step toward commercialising its UK recycling facility.

Anteris Technologies Global Corp. has filed a Form S-1 registration statement with the SEC to enable resale of shares issued in a recent private placement, marking a key step in advancing its DurAVR transcatheter heart valve system and pivotal clinical trials.

RareX Limited has signed a historic Mining Heritage Protection Agreement with the Jaru people, clearing a major hurdle for the Cummins Range rare earths project and paving the way for a Mining Lease.

Imugene Limited and JW Therapeutics have launched a strategic collaboration to combine oncolytic virus and CAR-T cell therapies, aiming to tackle refractory solid tumors through a pioneering 'mark and kill' approach.

Algorae Pharmaceuticals has secured a key distribution agreement with global giant Dr. Reddy’s Laboratories to supply the chemotherapy drug Capecitabine in Australia, marking a significant step in its oncology commercialisation strategy.

3D Energi has confirmed a promising gas-condensate find at the Essington-1 well using innovative Ora formation testing, marking the technology's Australian debut and setting the stage for further exploration in the Otway Basin.

International Graphite Limited has finalized the purchase of industrial land in Collie, Western Australia, setting the stage for Australia’s first commercial graphite micronising facility amid rising global demand.